Key result
Hepatic Angptl8 expression is rhythmically regulated by LXRα during feeding and glucocorticoid receptor signaling during fasting, and its overexpression dramatically elevates plasma triglyceride and non-esterified fatty acid levels in dexamethasone-treated mice.
Population
Eight- to twelve-week-old C57BL/6J male mice, liver-specific Bmal1-knockout mice, cultured mouse primary…
Comparison
Fasting/refeeding protocols, dexamethasone… vs Ad libitum feeding, vehicle/PBS injection, or…
Design
Preclinical, Mice were randomly separated into groups
Authors
Loading...
Should not yet change lipid management with glucocorticoids; leaves open Angptl8 targeting for dyslipidemia in humans.
Angptl8 expression is diurnally regulated by fasting/feeding signals via LXRα and GR, and its overexpression exacerbates hypertriglyceridemia in glucocorticoid-treated mice, highlighting its role in lipid homeostasis.
Dang et al. (2016) studied Hypertriglyceridemia and Lipid Metabolism. Fasting/feeding signals and Glucocorticoids (Dexamethasone) vs. Vehicle/PBS or ad libitum feeding was evaluated on Hepatic Angptl8 expression and plasma triglyceride/NEFA levels. Hepatic Angptl8 expression is rhythmically regulated by LXRα during feeding and glucocorticoid receptor signaling during fasting, and its overexpression dramatically elevates plasma triglyceride and non-esterified fatty acid levels in dexamethasone-treated mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: